Trademark: 88904727
Status Date
Wednesday, May 29, 2024
Filing Date
Thursday, May 7, 2020
Published for Opposition
Tuesday, October 5, 2021
5 House mark for a full line of pharmaceuticals; pharmaceuticals for human use, namely, pharmaceuticals for treatment and prevention of pain and allergic, inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions mediated via intracellular transport processes
42 Pharmaceutical research and development services
The mark consists of a design of five curved lines. The center of each line meets at the right side of the design, and the lines fan out to the left both above and below the center, forming an overall shape that resembles a curved arrow pointing to the right. The lines increase in width from left to right.
Color is not claimed as a feature of the mark.
Aug 10, 2020
Non-Final Action Written
May 11, 2020
New Application Entered
May 19, 2020
New Application Office Supplied Data Entered
May 20, 2020
Notice Of Design Search Code E-Mailed
Aug 4, 2020
Assigned To Examiner
Aug 10, 2020
Non-Final Action E-Mailed
Aug 10, 2020
Notification Of Non-Final Action E-Mailed
Feb 5, 2021
Teas Response To Office Action Received
Feb 5, 2021
Correspondence Received In Law Office
Feb 5, 2021
Teas/Email Correspondence Entered
Feb 7, 2021
Previous Allowance Count Withdrawn
Feb 7, 2021
Approved For Pub - Principal Register
Feb 24, 2021
Final Refusal Written
Feb 24, 2021
Final Refusal E-Mailed
Feb 24, 2021
Notification Of Final Refusal Emailed
May 21, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
May 21, 2021
Teas Change Of Owner Address Received
May 21, 2021
Teas Change Of Correspondence Received
Aug 19, 2021
Teas Request For Reconsideration Received
Aug 19, 2021
Correspondence Received In Law Office
Aug 20, 2021
Teas/Email Correspondence Entered
Aug 28, 2021
Approved For Pub - Principal Register
Sep 15, 2021
Notification Of Notice Of Publication E-Mailed
Oct 5, 2021
Published For Opposition
Oct 5, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 30, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 14, 2022
Sou Teas Extension Received
Apr 14, 2022
Sou Extension 1 Filed
Apr 14, 2022
Sou Extension 1 Granted
Apr 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 24, 2022
Sou Teas Extension Received
Oct 24, 2022
Sou Extension 2 Filed
Oct 24, 2022
Sou Extension 2 Granted
Oct 26, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 18, 2023
Sou Teas Extension Received
Apr 18, 2023
Sou Extension 3 Filed
Apr 18, 2023
Sou Extension 3 Granted
Apr 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 24, 2023
Teas Change Of Owner Address Received
Jul 24, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 24, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 24, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 24, 2023
Teas Change Of Correspondence Received
Nov 7, 2023
Sou Teas Extension Received
Nov 7, 2023
Sou Extension 4 Filed
Nov 7, 2023
Sou Extension 4 Granted
Nov 9, 2023
Notice Of Approval Of Extension Request E-Mailed
May 29, 2024
Teas Statement Of Use Received
May 29, 2024
Sou Teas Extension Received
May 29, 2024
Sou Extension 5 Granted
May 29, 2024
Sou Extension 5 Filed
May 30, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
